Before the first wave of the pandemic had tailed off and the second wave fears were not yet borne out, MassMutual Ventures’ Ryan Collins expressed a regret: he wished that that his Asia-focused venture capital firm had done more deals going into 2020, before the coronavirus first slowed business, and then changed the way it had to be done.
Collins, a partner at the Singapore-based branch of MMV, was addressing an In Vivo-hosted panel at the APACMed annual conference,...